CYTK
HEALTHCARECytokinetics Inc
AI Insight
What's Moving CYTK Today?
No stock-specific AI insight has been generated for CYTK yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$32.66$80.80
$81.35
Fundamentals
Market Cap$10.9B
P/E Ratio—
EPS$-6.85
Dividend Yield—
Dividend / Share—
ROE-572.0%
Profit Margin—
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding135.8M
CYTK News
27 articles- Cytokinetics Gains 18.4% Year to Date: How to Play the Stock?Yahoo Finance·Jun 17, 2026
- Edgewise Bounds Between Double-Digit Losses And Gain — What's Going On?Yahoo Finance·Jun 16, 2026
- Edgewise heart drug passes key trial testBioPharma Dive·Jun 16, 2026
- Cytokinetics (CYTK) Launches MYQORZO in Germany for Obstructive HCM TreatmentYahoo Finance·Jun 13, 2026
- Assessing Cytokinetics (CYTK) Valuation After First MYQORZO Launch In GermanySimply Wall Street·Jun 9, 2026
- Cytokinetics Announces Call for Proposals for Annual Corporate Giving ProgramYahoo Finance·Jun 8, 2026
- First MYQORZO Launch In Germany Might Change The Case For Investing In Cytokinetics (CYTK)Yahoo Finance·Jun 8, 2026
- Why Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?Yahoo Finance·Jun 4, 2026
- Cytokinetics Launches MYQORZO® (aficamten) in European Union, with First Commercial Availability in GermanyYahoo Finance·Jun 1, 2026
- Does Bullish Myqorzo Launch Coverage and New Shelf Registration Change The Bull Case For Cytokinetics (CYTK)?Simply Wall Street·Jun 1, 2026
- Citi Calls Cytokinetics, Incorporated (CYTK) a “Top Pick” Among Small-to-Mid Cap Biotech StocksYahoo Finance·May 28, 2026
- Cytokinetics to Participate in June Investor ConferencesYahoo Finance·May 27, 2026
- A Look At Cytokinetics (CYTK) Valuation After A Strong Multi‑Year Share Price PerformanceYahoo Finance·May 25, 2026
- Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026Yahoo Finance·May 24, 2026
- Cytokinetics Says MYKORZO Launch Tops Expectations as HCM Data Draws PraiseMarketbeat·May 22, 2026
- Cytokinetics to Hold Annual Meeting of StockholdersYahoo Finance·May 20, 2026
- How New Aficamten Phase 3 Data and Equity Raise Will Impact Cytokinetics (CYTK) InvestorsSimply Wall Street·May 19, 2026
- StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst callsYahoo Finance·May 19, 2026
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)GlobeNewswire·May 19, 2026
- Cytokinetics Inc stock (US2328281044): CLIMB muscle biology symposium adds to MYQORZO launch momentumAD HOC NEWS·May 15, 2026
- Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)Yahoo Finance·May 14, 2026
- Cytokinetics to Participate in the 2026 RBC Capital Markets Global Healthcare ConferenceYahoo Finance·May 12, 2026
- Growth Investors: Industry Analysts Just Upgraded Their Cytokinetics, Incorporated (NASDAQ:CYTK) Revenue Forecasts By 11%Yahoo Finance·May 12, 2026
- Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026Yahoo Finance·May 11, 2026
- Identifix’s Direct-Hit® Mobile Brings OEM Repair Manuals to the Bay, Transforms How Repairs Get DoneYahoo Finance·May 11, 2026
- Cytokinetics: Aficamten Has Momentum, But The Stock Is Too Expensive (NASDAQ:CYTK)Seeking Alpha·May 10, 2026
- Cytokinetics to Announce First Quarter Results on May 5, 2026GlobeNewswire Inc.·Apr 21, 2026
All 27 articles loaded
Price Data
Open$80.53
Previous Close$80.01
Day High$82.83
Day Low$79.12
52 Week High$80.80
52 Week Low$32.66
52-Week Range
$32.66$80.80
$81.35
Fundamentals
Market Cap$10.9B
P/E Ratio—
EPS$-6.85
Dividend Yield—
Dividend / Share—
ROE-572.0%
Profit Margin—
Debt / Equity—
Trading
Volume1.8M
Avg Volume (10D)—
Shares Outstanding135.8M
About Cytokinetics Inc
Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering, developing and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is headquartered in South San Francisco, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—